Press Releases

Year

May 27, 2020

Planning for Future Pandemics Including Smallpox Outbreaks: Interview with Dr. Phil Gomez, CEO, SIGA Technologies

May 06, 2020

SIGA Technologies, Inc. Reports Financial Results for the First Quarter of 2020

- Company Recently Announced Exercise of Contract Options Totaling $101.3 million - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK , May 06, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health

Apr 29, 2020

SIGA Announces BARDA Exercise of Contract Options Valued at $101.3 Million for the Procurement of Oral TPOXX®

Deliveries to Maintain National Security Expected to Start in Second Quarter 2020 NEW YORK , April 29, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced the exercise of

Apr 29, 2020

SIGA Technologies to Host Business Update Call on May 6, 2020 after Release of First Quarter Financial Results

NEW YORK , April 29, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M.

Apr 03, 2020

SIGA Announces Award of First International Contract for Oral TPOXX® with Purchase by the Canadian Department of National Defence

- Contract for up to $14.3 million for 15,325 Courses - NEW YORK , April 03, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the Canadian Department of National Defence

Mar 05, 2020

SIGA Technologies, Inc. Reports Financial Results for Fiscal Year 2019

- Announces Expectations for Product Delivery to BARDA - - Announces $50 Million Share Repurchase Program - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK , March 05, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company

Mar 02, 2020

SIGA Announces Collaboration with Turnstone Biologics

SIGA to supply TPOXX ® To Support Turnstone’s SKV Vaccinia Oncolytic Viral Immunotherapy Program NEW YORK , March 02, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it

Feb 20, 2020

SIGA to Host Business Update Call on March 5, 2020 after Release of Year End Financial Results

NEW YORK , Feb. 20, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M.